Clovis Oncology Inc

NASDAQ:CLVS  
4.35
-0.10 (-2.25%)
4:24:50 PM EDT: $4.36 +0.01 (+0.23%)
Debt Financing / Related

Clovis Oncology Retires Remaining 2021 Notes And Raises Additional Capital Through Its ATM Equity Offering Program

Published: 09/20/2021 12:19 GMT
Clovis Oncology Inc (CLVS) - Clovis Oncology Retires Remaining 2021 Notes and Raises Additional Capital Through Its Atm Equity Offering Program.
Clovis Oncology Inc - Three Phase 3 Topline Rubraca Data Readouts Expected in 2022.
Clovis Oncology Inc - Initial Data From Lumiere Study of Targeted Radiotherapy Candidate Fap-2286 Also Expected in 2022.